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ABSTRACT

Maharjan, Chandra Kumar. M.S. Department of Pharmacology and Toxicology, Wright
State University, 2016. Interaction of Na+/K+ ATPase with Bcl-2 Proteins: Isolated
Enzyme vs Epithelial Cell Extracts.

The nearly complete inhibition of Na+/K+ ATPase (NKA) in fetal human lens (FHL)
epithelial cells by chelerythrine (CHE), a Bcl-2 homology (BH)3-mimetic quaternary
benzophenanthridine alkaloid was proposed to be the consequence of CHE binding at a
BH1-like hydrophobic groove at the cytosolic aspect of NKA. This conclusion was based
on in silico analysis showing at least two motifs in the N-terminal domain of NKA’s α1
subunit- i) aa 59-71 (ARAAEILARDGPN) and ii) aa 42-48 (DELHRKY) homologous to
the BH1 and BH3 motifs of Bcl-2 (B-cell lymphoma) respectively, leading to a novel
hypothesis that NKA could interact with these proteins by virtue of BH1/BH3 motifs
(Lauf et al, 2013). Subsequently, based on the findings of co-immunoprecipitation (co-IP)
and immuno-cytochemical (ICC) colocalization, NKA was proposed to directly interact
with Bcl-XL (Bcl extra large) and a different spliced Bak (Bcl-2 antagonist killer)
isoform (Lauf et al, 2015). In the early studies, NKA pulled down Bcl-XL and a 4 kDa
higher molecular weight protein band purported to be an isoform of Bak (MW 23 kDa),
however, the reciprocal co-IP of NKA by these Bcl-2 proteins couldn’t be established
(Lauf et al, 2015).
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The initial objective of the present work was to confirm the significance of the BH1 like
motif in the α1 subunit of isolated and purified pig renal NKA (prNKA) for its interaction
with Bcl-2 proteins. The attempt to demonstrate, by co-IP, the in vitro binding of a Bak
eicosapeptide containing a conserved BH3 motif to prNKA (prepared according to
Klodos et al, 2002) serendipitously revealed a ~25 kDa band when the immunoblot was
probed with a combination of anti-Bak as primary and Fc fragment specific-goat anti-rb
IgG as secondary antibody. Though this protein band was initially thought to be prBak,
presumably contaminating the preparation as a complex with prNKA, the use of Veriblot
secondary antibody against non-reduced IgG could not confirm this assumption revealing
instead a ~25 kDa protein which seems to be the light (L) chain of an IgG contaminant of
prNKA.
Substituting the previously used L chain-cross reactive secondary antibody with Veriblot,
the co-IP between NKA and Bak was reassessed in FHL cells. Again, in this preparation,
NKA failed to pull down Bak and the previously observed ~27 kDa band in the NKA coIP lane appears to be L chain. The co-IP between Bcl-XL and NKA in FHL cells was
revisited using a similar approach. However, under the present conditions, Bcl-XL did
not co-IP with NKA. Because of the absence of Bcl-XL in Bak co-IP (serving as a
positive control), the credibility of these findings is diminished and shows the difficulty
in establishing the BH1/BH3 motif interaction. Furthermore, NKA could not co-IP Mcl1, a higher molecular weight anti-apoptotic Bcl-2 protein, from the FHL lysate. However,
ICC colocalized again unequivocally NKA, separately, with Bak, Mcl-1, and Bax, as
with Bcl-XL before in FHL cells consistent with our previous conclusion that these
proteins lie in close proximity possibly interacting with each other. To explain the
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discrepancy between the co-IP and ICC findings, it is proposed that the putative
BH1/BH3 interaction of NKA with Bcl-2 proteins is conformation-dependent requiring
optimum ionic and hydrophobic environments and the presence of specific ligands,
conditions which are very likely to be compromised in the process of a co-IP technique.
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I.

INTRODUCTION AND BACKGROUND

Sodium/Potassium (Na+/K+) Adenosine Triphosphatase (ATPase)
Na+/K+ ATPase (NKA), first characterized in 1957 by Skou as an ATP hydrolyzing
enzyme involved in the active extrusion of Na+ in a crab nerve, is a membrane transporter
expressed in animal cells (Skou, 1957). NKA pumps three Na+ out of and two K+ into
the cell at the expense of one ATP molecule during its catalytic cycle thus playing a key
role in creating an electrochemical gradient of these cations across the cell membrane.
This gradient is vital for the maintenance of resting membrane potential and also acts as
an energy source for de-and re-polarization of the membrane. Moreover, this unequal
distribution of cations is required for the regulation of cell volume and cytoplasmic pH,
active transport of some nutrients, and co- or counter-transport of other ions across the
cell membrane (Skou and Esmann, 1992). NKA’s energy consumption is estimated to be
around 30% of the total energy used by a cell at rest (Aperia, 2007). Inhibition of NKA
by cardiac glycosides like digitoxin, digoxin and ouabain has been pharmacologically
exploited in the management of congestive cardiac failure. These glycosides seize the
pumping activity of NKA that leads to the accumulation of Na+ ions inside the cell
followed by an increase in cytosolic Ca2+ by the subsequent reverse activation of the
Na+/Ca2+ exchange system. The intracellular loading of Ca2+ in cardiac myocytes
improves their contractility.
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Structure of NKA

NKA is a member of the P-type ATPases, the family of integral membrane transport
proteins that undergo a phosphorylated intermediate state during their catalytic iontransport cycle (Bublitz et al, 2011). Structurally, it is a hetero-trimer consisting of: a) α
subunit, b) β subunit, and c) γ subunit.
The α subunit is a 110 kDa polypeptide with approximately 1020 amino acids which
executes the catalytic and transport functions of NKA, and possesses the binding sites for
cations, ATP, and cardiac glycosides. Four distinct isoforms of the α subunit showing a
high degree of identity have been recognized to date. The expression of these isoforms in
vertebrates varies according to the type of cells or tissues (Skou and Esmann, 1992). The
α1 subunit isoform is ubiquitously expressed, however, predominantly in kidney cells and
cells of epithelial origin (Kaplan, 2002); α2 in adipocytes, muscle, heart, and brain; α3 in
nervous tissue; and α4 in spermatozoa (Panayiotidis et al, 2006).
As depicted in the diagrammatic representation of NKA (Fig. 1), the α subunit consists of
ten helical transmembrane domains (TMDs) forming several intracellular loops (ICLs)
and extracellular loops (ECLs) and has its N- and C-terminal domains (NTD and CTD) in
the cytoplasmic region. The cytoplasmic part of this subunit harbors three domains
important for its catalytic function: actuator (A-), nucleotide binding (N-) and
mphosphorylation (P-) domains. The A-domain comprises the NTD and first ICL (ICL1)
whereas, N- and P- domains are located at ICL2 with the former pushed towards the latter
(Reinhard et al, 2013). The rotation of A-domain by 120° protects the acyl-phosphate
formation and plays a crucial role in the movement of TMDs required for the transport of
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ions. ATP binds to a highly conserved site in the N-domain to facilitate the
phosphorylation at asp 369 present in the P-domain (Bublitz et al, 2011). Moreover, the α
subunit is known to contain a highly conserved binding site for cardiac glycosides formed
by ECL 1 (between TMD 1 and 2), 2 (between TMD 3 and 4) and 3 (between 5 and 6)
(Prassas and Diamandis, 2008).

Figure 1: A diagrammatic representation of NKA heterotrimer showing its α (dark blue),
β (green) and γ (grey) subunits. 1-10 TMDs are shown as blue cylindrical structures
trapped within a bi-layered membrane. NH2 and COOH represent the N-terminus and Cterminus of subunits respectively. The shaded regions represent the cytosolic domains of
α subunit namely- actuator (A-), nucleotide binding (N-) and phosphorylation (P-)
domains. (adapted from the schematic representation of NKA by Reinhard et al, 2013).
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The β subunit is the second subunit with a molecular weight of 55 kDa and is composed
of approximately 370 amino acids. It is formed of a short N-terminal cytosolic domain
(with 30 amino acids), a transmembrane helix and a highly glycosylated C-terminal
ectodomain (Fig. 1). The β subunit helps in the translocation of the α subunit to the cell
membrane by forming an α-β complex (Kaplan, 2002). In humans, the β subunit exists in
three isoforms, β1, 2, and 3, showing a less degree of sequence identity between one
another (Reinhard et al, 2013).
Also referred to as FXYD protein (because of a characteristic motif formed by
phenylalanine, tyrosine and aspartate), the γ subunit is the smallest subunit of NKA with
a molecular weight of about 12 kDa. The cytosolic C-terminal peptide interacts with the α
subunit in a redox-dependent manner (Liu et al, 2013). Known to exist in seven different
isoforms, it regulates the pumping activity of NKA (Forbush et al, 1978).

Post-Albers canonical cycle
Post-Albers transport cycle of NKA enzyme (E, schematically illustrated in Fig. 2)
involves a cation-dependent E1 to E2 conformational change that is coupled to ATP
hydrolysis (Pierre and Xie, 2006). The occlusion of 3 Na+ to E1-ATP conformation
catalyzes the phosphorylation of α subunit at asp 369 resulting in a high energy complex,
Na3E1P-ADP, which is a rate limiting step. The release of ADP is accompanied by the
loss of 1 Na+ extracellularly giving rise to the Na2E2P conformation, which supports
cardiac glycoside binding. E2P has a reduced affinity for Na+ so that in the next step, Na+
ions are expelled to the outside of the cell and are replaced by 2 K+ ions coming from the
same direction. The resulting K2E2P state undergoes auto-hydrolysis to release a
phosphate moiety (Pi) and upon ATP binding to the N domain, K+ ions are discharged to
4

the cytosol restoring the E1-ATP conformation of NKA (Post et al, 1965 and Albers,
1967).

Figure 2: A schematic representation of Post-Albers canonical transport cycle of NKA.
(Adapted from the reaction cycle of a P-type ATPase by Morth et al, 2011)

Signaling functions of NKA
Conventionally known to regulate ionic homeostasis within a cell, NKA’s role as a signal
transducer has recently been garnering much attention. Sub-saturating concentrations of
ouabain (the cardiac glycoside being widely used to study protein-protein interactions of
NKA), causing partial or no inhibition of NKA’s pumping activity, have been found to
unleash various signaling cascades by effecting the interaction of the enzyme with
specific secondary messengers (Aperia et al, 2016 and Haas et al, 2002).
That NKA directly interacts with Src kinase (a non-receptor tyrosine kinase) through
multiple domains and modulates downstream events has been proposed and extensively
studied by Xie et al (2006). The direct interaction between these two proteins has been
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demonstrated by co-immunoprecipitation and fluorescence resonance energy transfer
(FRET) analysis (Pierre and Xie, 2006). The two intracellular loops (ICLs)- ICL1 and
ICL2 of NKA are thought to interact respectively with SH2SH3 and kinase domains of
Src kinase forming a non-functional receptor complex (Pierre and Xie, 2006). Upon
binding of ouabain, NKA’s interaction with the Src kinase domain was found to be
hindered. This activates Src kinase by exposing and auto-phosphorylating Tyr418 of its
kinase domain (Tian et al, 2006). Activated Src kinase trans-phosphorylates epidermal
growth factor receptor (EGFR) which, in turn, triggers a Ras-Raf-MAPK (mitogenactivated protein kinase) signaling cascade leading to ROS (reactive oxygen species)
generation and gene activation (Xie and Cai, 2003).
Furthermore, the serendipitous finding of Aperia et al (2001) that the sub-saturating
concentrations of ouabain generates Ca2+ oscillatory signals in renal epithelial cells has
led to the discovery of NKA’s interaction with and activation of inositol 1,4,5
triphosphate receptor (IP3R) (Aizman et al, 2001). The subsequent studies in this area
have revealed that this interaction is between the N-terminus of the NKA α subunit and
the N-terminus of the IP3R receptor (Zhang et al, 2006) and is not regulated by
phospholipase C (PLC), another protein that is known to interact with NKA and remain
in close vicinity of the NKA-IP3R signaling complex (Miyakawa-Naito et al, 2003).
These calcium oscillations, depending on the periodicity and duration (Zhang et al,
2006), could have pleiotropic end results like cell growth, differentiation and apoptosis
(Dolmetsch et al, 1998).
Besides these two well-defined pathways, NKA, upon activation by ouabain or
constitutively, has also been demonstrated to interact with and regulate the functioning of
6

caveolins (Pierre and Sandrine, 2006), ankyrins (Liu et al, 2008), translationally
controlled tumor protein (TCTP) (Jung et al, 2004), and also with many structural and
membrane proteins (Askari, 2000) as well as upon stimulation by dopamine, with
phosphatidylinositol-3-kinase (PI3K) (Yudowski et al, 2000). Moreover, the
demonstration of direct physical interaction between NKA α1 subunit and Bcl-2 in lens
epithelial cells by Lauf et al in 2015 has broadened the scope of NKA as a signal
transducer.

An overview of Bcl-2 proteins
Bcl-2 family proteins, named after its founding member B-cell lymphoma 2 (Bcl-2), is a
group of proteins that induce or inhibit cell apoptosis mediated by the permeabilization of
mitochondrial outer membrane (MOM). Each protein of this family bears sequence
homology to the prototypal member, Bcl-2, in at least one of the four canonical Bcl-2
homology (BH) domains- BH1 through BH4 as illustrated in Fig. 3 (Shamas-Din et al,
2013 and Shangary et al, 2002). The carboxy-terminal of most of these proteins contain a
sequence of hydrophobic amino acids forming a membrane-binding region that facilitates
their insertion and localization to the MOM, endoplasmic reticulum (ER) membrane
(Shamas-Din et al, 2013), and plasma membrane (Bruce-Keller et al, 1998). Based on
their role in the regulation of cell death and the number of BH domains present, these
proteins are sub-grouped into following categories.
a) Anti-apoptotic proteins:
Anti-apoptotic proteins are Bcl-2, Bcl-XL (B-cell lymphoma-extra large), Mcl-1
(myeloid cell leukemia 1), and Bcl-w, which contain all four BH1-4 domains. Localized
predominantly on the outer membranes of mitochondria, ER, nuclear, and plasma
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membranes, these proteins bind to and sequester multi-domain or BH3 only pro-apoptotic
proteins and impede their activation (Shamas-Din et al, 2013).
b) Pro-apoptotic proteins:
i)

Multi-domain executioners: Bak (Bcl-2 antagonist killer) and Bax (Bcl-2
associated ‘x’) are two classic examples of proteins belonging to this
category. They possess only three BH domains, BH1-3. Bak is mainly
found on MOM whereas Bax in cytosol (but translocates to mitochondria
after activation) (Wolter et al, 1997). After receiving an apoptotic
stimulus, these proteins undergo conformational change to form homooligomers that can mediate the MOM permeabilization leading to the
release of cytochrome c and subsequent activation of caspases.

ii)

BH3 only proteins: These are relatively small proteins possessing a single
BH3 domain. These proteins can either directly or indirectly activate the
multi-domain pro-apoptotic proteins. On the basis of their relative affinity
towards the multi-domain Bcl-2 family proteins, these have been subgrouped into activators and sensitizers (Letai et al, 2002). The activator
BH3 proteins- tBid, Bim, and Puma- can bind to both the anti-apoptotic
and pro-apoptotic Bcl-2 proteins and thereby, are able to directly activate
the latter during cell injury or stress. On the other hand, the sensitizersBad, Noxa, Bik, Bmf, Hrk, and Bnip3- can interact only with the antiapoptotic proteins to displace the sequestered BH3 activators or BH1-3
executioners and lead to their activation (Letai et al, 2002).
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Figure 3: Schematic representation of Bcl-2 family of proteins. (modified from the
overview of the Bcl-2 family proteins illustrated by Shamas-Din et al, 2013)

Interaction of NKA with Bcl-2 proteins
The concept behind the interaction of NKA with Bcl-2 proteins originated from the
discovery of certain amino acid (aa) sequences in its α1 subunit which are significantly
identical to the canonical BH1 or BH3 motifs of Bcl-2 family proteins- Bcl-2 and Bcl-XL
(Lauf et al, 2013). This in silico analysis was performed against the backdrop of some
interesting findings associated with the inhibition of NKA by chelerythrine (CHE), a
quaternary benzophenanthridine alkaloid and protein kinase C (PKC) inhibitor. CHE
almost completely inhibited NKA activity at 50 µM concentration after 20 min
incubation time. This inhibition was, however, found to be PKC-independent and not via
a competitive binding to the ouabain receptor. Moreover, the data from surface-enhanced
Raman spectroscopy (SERS) revealed the higher uptake of CHE in the cytosolic and
plasma membrane fractions of fetal human lens (FHL) epithelial cells (Dorney et al,
9

2013). Already known to dock into the BH1 groove of Bcl-XL displacing Bax (Chan and
Yu, 2004), CHE was thereby believed to interact with and inhibit NKA also by virtue of
its BH3 mimetic properties.
The in silico analysis revealed two such sequences which have garnered much interest: i)
a 13 aa sequence (ARAAEILARDGPN) from aa 59-71 in the N-terminal domain of NKA
α1 which is 71% similar to the aa 124-136 (EQVVNELDRFGVN) and the 131-143
(ATVVEELFRDGVN) motifs lying in the BH1 regions of Bcl-XL and Bcl-2
respectively; ii) a stretch of aa 42-48 (DELHRKY) also in N-terminal domain that is
closely homologous to the BH-3 like motifs- aa 95-101 (DEFELRY) and aa 102-108
(DDFSRRY) present in Bcl-XL and Bcl-2 respectively. Since the BH1 domain primarily
contributes to form a hydrophobic groove in anti-apoptotic proteins that binds with the
BH3 motifs of pro-apoptotic Bcl-2 family proteins like Bak (Chan and Yu, 2004) to form
hetero-dimers or oligomers, observation of similar canonical motifs in NKA set up a
rationale to investigate its physical interaction between Bcl-2 proteins.
Several evidences based on immunochemical techniques have been revealed so far to
demonstrate the direct physical interaction between NKA α1 subunit and Bcl-2 proteinsBcl-XL and Bak (Lauf et al, 2015). NKA co-immunoprecipitated both BclXL and Bak in
FHL 124 cells. Importantly, in FHL 124 cells, NKA has been shown to co-localize with
Bcl-XL and Bax through immunofluorescence experiments, supporting the argument that
these proteins lie in close proximity and might form a functional complex. The molecular
weight of Bcl-XL pulled down by NKA conforms to that observed in input and selfpulldown in the Western blotting results. Probing for Bak in immunoblots after coimmunoprecipitation (co-IP) experiments resulted in a ~27 kDa band in the NKA10

pulldown lane in contrast to 23 kDa bands in input and homo-pulldown by anti-Bak
antibodies. It was hence proposed that NKA interacts with and pulls down a different,
spliced isoform of Bak (with higher molecular weight) in FHL cells. Moreover, there was
no reciprocal pull down of NKA by either of the antibodies against Bcl-XL or Bak.
The present study reassesses the interaction of NKA with Bcl-2 proteins by comparing
the results of co-IP performed in pig renal NKA preparation (Klodos et al, 2002) with
that in FHL lysate. The purified preparation of NKA from pig kidney was tested for the
presence of Bak and Bcl-XL, supposedly as a complex with α1 subunit. The results from
these experiments, despite not revealing Bak or Bcl-XL in the preparation, elucidated the
confounding nature of IgG- light (L) chain detection in immunoblots as it could be
potentially misinterpreted as Bcl-2 proteins of similar molecular weights. The use of
Veriblot secondary antibodies for co-IP unambiguously demonstrated that NKA couldn’t
co-immunoprecipitate Bak from FHL cell lysate at the given experimental conditions,
moreover, the 27 kDa band, previously observed in NKA pull down and reported as
spliced Bak isoform (Lauf et al, 2015), could potentially be the L chains of antibodies
used for co-IP. The co-IP of Mcl-1, a larger Bcl-2 protein with ~45 kDa molecular
weight, by anti-NKA antibody and vice versa produced negative results like in case of
Bak suggesting that our experimental conditions for co-IP could be less conducive for the
interaction of NKA and Mcl-1 or Bak. On the other hand, our results on immunecytochemistry depicting the co-localization of NKA with Bak, Bax and Mcl-1 in FHL
cells confirmed that these proteins lie in close proximity in FHL cells potentially forming
a functional complex, and thus add on to the ICC significance of NKA-Bcl-XL
colocalization shown earlier (Lauf et al, 2015).
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II.

MATERIALS AND METHODS

Chemicals
Dimethyl sulfoxide (DMSO), sodium chloride (NaCl), potassium chloride (KCl),
disodium phosphate (Na2HPO4), Tris base (Tris(hydroxymethyl)aminomethane), glycine,
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), magnesium chloride
(MgCl2), glucose, methanol, 1-butanol, ammonium persulfate, bis-acrylamide, and
acrylamide were purchased from Fisher Scientific, NJ. Trypsin 0.05 % (Hyclone
Laboratories), sodium dodecyl sulphate (Invitrogen), i-block (Applied Biosystems),
Dynabeads protein G (Life technologies), development folders (Applied Biosystems),
10X assay buffer (Applied Biosystems), Tropix CDP star and Nitroblock II (Applied
Biosystems), N,N,N’N’-Tetramethylethylenediamine (TEMED, Gibco BRL, Life
technologies), Spectra multicolor broad range protein ladder, Halt protease inhibitor,
Pierce RIPA buffer, Supersignal west pico chemiluminescent substrate, and stripping
buffer were procured from Thermofisher, MA. 2X Laemmli Sample Buffer, 10-20 %
Tris-tricine gel, 12.5 % tris-HCl gel, 4-15 % Tris-HCl gel, nitrocellulose membranes
(0.45 µm), and Criterion blotter filter paper were obtained from BioRad, CA. Other
chemicals, used for this project, were β-mercaptoethanol and ouabain octahydrate from
Calbiochem, CA; dithiothreitol from EMD, NJ; tween 20 from VWR, PA; potassium
dihydrogen phosphate (KH2PO4) and calcium chloride from J.T. Baker Chemical Co.,
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NJ; protein G- agarose from Roche Diagnostics, IN, and IGEPAL CA-630 from MP
biologicals, France.

Antibodies
Primary rabbit (rb) monoclonal- [Y37] anti-Mcl-1, [E18] anti-Bcl-XL, [E63] anti-Bax
[Y164] and anti-Bak antibodies were obtained from Abcam Biotech, Cambridge,
England; rb polyclonal anti-Bak, normal mouse (ms) IgG, and normal rb IgG from Santa
Cruz Biotechnology, TX; ms monoclonal anti-Na+/K+ ATPase (NKA) α1 subunit (α6f)
from Developmental Studies Hybridoma Bank (DSHB), IA. Additionally, rb polyclonal
anti-Bak was acquired from Cell Signaling Technology, MA and ms monoclonal antiNKA from EMD Millipore Corporation, MA. Secondary antibodies for Western blotting
were alkaline phosphatase (AP) conjugated- ms monoclonal anti-rb IgG light (L) chainspecific, affinipure goat (gt) anti-ms IgG L chain-specific and affinipure gt anti-rb IgG Fc
fragment from Jackson Immunoresearch Laboratories, PA. In addition, horseradish
peroxidase (HRP) conjugated-Veriblot secondary antibody from Abcam was used in
many of our co-IP experiments. For immune-cytochemical staining experiments,
secondary antibodies conjugated with fluorescent cyanine (cy) and isothiocyanate (FITC)
dyes: cy3-conjugated donkey (dk) anti-ms IgG, FITC-conjugated dk anti-rb IgG, and
cy3-conjugated donkey anti-rb IgG were acquired from Jackson Immunoresearch
Laboratories.

Cell culture
Major portions of this dissertation work is based on either protein extracts or live cultures
of fetal human lens (FHL) 124 epithelial cells. The genomic information of this primary
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cell line is well established (L. Wang, Wormstone, Reddan, and Duncan, 2005;
Wormstone et al., 2004). Gifted to us by Prof. John Reddan from Oakland University,
FHL 124 cells of passages ranging from 14 through 30 were cultured on T-75 flasks
(Biolite 75 cm2, Thermofisher Scientific, Newark, NJ), 100 x 20 mm Petridishes
(Corning Life Sciences, Tewsbury, MA) or chambered slides (Millicell EZ slide,
Millipore, MA). A solution of 2 % Type B gelatin (Sigma Aldrich, MO) was used to coat
the bottom surface of flasks and dishes before seeding cells. The growth medium consists
72 % Hyclone M199/Earle’s balanced salt solution (EBSS, Fisher scientific, NJ), 18 %
keratinocyte basal medium (KBM, Lonza, MD), 5 % Hyclone heat-inactivated fetal clone
serum (Fisher Scientific), heat inactivated horse serum (Gibco by Life Technologies,
NY), with 2.05 mL of Gentamicin (Sigma Aldrich, MO) per 500 mL of the final solution.
Optimum conditions for incubation of these cells include 5 % CO2, 95 % O2 and
temperature of 37 °C.

Protein Extraction
FHL 124 cells were seeded onto 8 pre-gelatinized Petri dishes and grown to confluence.
The dishes were placed on ice and the cells were washed with 5 mL per dish of balanced
salt solution (BSS, with composition: 20 mM HEPES-Tris, 5 mM KCl, 2 mM CaCl2, 1
mM MgCl2, 10 mM glucose at 300 mOsm final osmolality). After the second wash with
5 mL of 1x phosphate buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4 and 2mM KH2PO4), the cells from each dish were scraped into a mixture of 2
mL 1x PBS and 20 mL Halt protease inhibitor, transferred into separate Eppendorf tubes
and centrifuged for 10 min at 13,500 rpm at 4 °C in a Beckman Elutriator Centrifuge to
obtain cell pellets. After discarding the supernatant, 150 µL of RIPA (Radio
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Immunoprecipitation Assay) buffer or less stringent NP-40 buffer (150 mM NaCl, 1 %
NP-40 or Triton X-100, 50 mM Tris pH8.0) was added to each tube and pipetted up and
down to break up the cell pellets. The tubes, placed on ice bath for 36 min, were vortexed
every 6 min. The suspension on each tube was then sonicated with a Misonix-3000
(Cole-Parmer, Vernon Hills, IL 60061 USA) ultrasonic cell disrupter for 3-4 sec at low
setting of 6 W (RMS) on ice. Finally, the sonicated samples were centrifuged at 13,500
rpm at 4 °C for 10 min to harvest the supernatants which were stored at -80 °C.

Protein analysis
Volumes of 1 mg/ml bovine serum albumin (BSA), ranging from 2 to 10 µL, were treated
with 1:5 dilution of Bio-Rad protein assay dye reagent (Bio-Rad, CA), the resulting
colored solutions transferred to a 96 well plate, and their optical densities measured in
order to get a standard plot of absorbance (at 595 nm) vs concentration of protein. In a
similar fashion, 2 µL of extracted FHL protein solution was mixed with the dye and then
transferred into the same 96 well plate to read its optical density with Synergy H1
Microplate Reader (BioTek, VT). Finding the slope and y-intercept of the standard plot
using Origin 7 software, the unknown concentration of the FHL protein solution was
calculated.

Co-immunoprecipitation (co-IP)
Volumes of 50 µL of Dynabeads or agarose beads conjugated with Protein-G were added
to each of the required number of Eppendorf tubes and washed with EBC lysis buffer (50
mM Tris-Cl pH 7.4, 150 mM NaCl, and 0.5 % NP-40 detergent) or NP-40 buffer (50 mM
Tris-Cl pH 8.0, 150 mM NaCl, 1% NP-40 or Triton X-100). A magnetic bar inserted into
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MagRack 6 (GE Health Life Sciences, PA) was used for the separation of Dynabeads.
Protein G-agarose beads were separated by centrifugation at 12,000 rcf (relative
centrifugal force). 500 µL of buffer was mixed with the recommended volume of an
antibody (80 µL of anti-NKA, α6f or 5-10 µL of anti-Bcl-XL, Bak, Mcl-1 or Bax) before
transferring the mixture to one of the tubes with beads. 50 µL each of normal (nonimmune) ms IgG and rb IgG were used as negative controls of co-IP. All tubes with
beads and specific or non-specific (non-immune) antibody solutions were incubated at 4
°C for 2 h in by rotating end-over-end. Following incubation, the beads were re-captured
by a magnetic bar or separated by centrifugation, washed once with EBC or NP-40
buffer, treated with FHL cell extract or pig renal NKA (PRNKA) purified protein,
prepared by the Klodos et al. procedure (Klodos et al., 2002) and a gift from Professor
Judy Heiny (University of Cincinnati, Dept. of Molecular Physiology), containing 5001000 µg of protein, and finally incubated for 2-4 h or overnight. The loaded beads were
then washed five times with the same buffer before adding 70 µL of sample preparation
buffer that consists 950 µL 2x Laemmli sample buffer (LSB), 50 µL of βmercaptoethanol (β-ME), and 111 µL of dithiothreitol (DTT). The resulting mixtures
were incubated at 65 °C for 30 min or 100 °C for 5 min and following this denaturation
and reduction of proteins, the beads were separated and supernatants containing proteins
were loaded into distinct wells of a gel for Western Blot.

Western blot
FHL cell lysate or pure PRNKA preparation were treated with a sample preparation
buffer (composed of 47.5 µL 4x Laemmli Sample Buffer, 2.5 µL β-ME, and 5.6 µL
DTT) and incubated similarly at 65 °C for 30 min or 100 °C for 5 min to be loaded as
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input into the gel. Gels were selected based on the type of study: 4-15 % Tris-HCl
Criterion gel, 12.5 % Tris-HCl Criterion gel, (both from Bio-Rad) and self-prepared 10 %
sodium dodecyl sulphate-polyacrylamide gels (SDS-PAGE) were used for protein
interaction studies on FHL lysates, however, 5-20 % Tris-Tricine gel (Bio-Rad) was used
for work on the PRNKA preparation. After loading Spectra multicolor broad range
molecular weight standards alongside input, co-IP samples and negative controls in a
definite order into the wells of a gel immersed in running buffer (25 mM Tris, 192 mM
glycine, and 0.1 % SDS, pH 8.4), gel electrophoresis was carried out at 150 volts for 90
min. Proteins separated in the gel were transferred onto a 0.45 µm nitrocellulose
membrane by using a transfer buffer (25 mM Tris, 192 mM glycine, and 10 % v/v
methanol) under the conditions: 70 mAmp for 999 min or 375 mAmp for 180 min in a
Bio-Rad transfer chamber. The membrane was then cut into desired sections, if
necessary, and washed twice with 0.1 % Tween 20, 1x PBS for 10 min each time, treated
for 0.5 h with a blocking solution (1 % I-block in 0.1 % Tween 20, 1x PBS) at 4 °C, and
incubated overnight at 4 °C with recommended dilutions (1:80 for α6f and 1:1000 for
anti-Bcl-XL, anti-Bak, anti-Mcl-1, or anti-Bax dissolved in blocking buffer) of primary
antibody. After adequate washing (two quick washes with three long washes of 10 min
each) with PBS-Tween buffer once again, the blots were subjected to treatment with AP
or HRP conjugated secondary antibody for 1 h at room temperature (RT); 1:50001:10000 was the range of dilution ratio for antibodies of former type whereas 1:2000 for
Veriblot. The membrane sections were washed five times again in the same manner. For
an AP-conjugated secondary antibody, washing with 1X assay buffer was required before
the final treatment for 5 min with a mixture of CPD-Star substrate and Nitroblock

17

reagents combined in 20:1 ratio. However, for Veriblot, the blots, after washing, were
directly exposed to SuperSignal West Pico Chemiluminescent Substrate (i.e. 1:1 mixture
of Luminol/Enhancer solution and Stable Peroxide solution). The blots were finally
wrapped into a development folder and visualized in Bio-Rad’s Chemidoc system under
‘hisensitivity’ and ‘hiresolution’ settings.

Immuno-fluorescence and cytochemical colocalization studies
FHL 124 cells were grown to confluence in T-75 flasks and trypsinized to prepare a cell
suspension. Cell counting of the suspension was performed by trypan blue exclusion
method on a Neubauer’s counting chamber. The cells were then seeded onto a pregelatinized 8-well chambered slide (Millicell EZ slide, Millipore, MA) at a concentration
of 5x104 cells/well and allowed to grow. On the second day of seeding, cells in the
chambered slide were washed with 1x PBS and thereafter, fixed and permeabilized with a
mixture of 4 % paraformaldehyde (PFA) and 0.1 % saponin for 30 min at 4 °C. After
three 10 min gentle washes on a shaker, cells were blocked for 1 h with 3 % normal dk
serum at 4 °C. The blocking solution was replaced by an intended pair of primary
antibodies diluted in blocking solution. Ms anti-NKA antibody (Millipore) diluted to a
working concentration of 7 µg/ml was paired with a) rb anti-Bak (Santa Cruz
Biotechnology) with dilution factor (DF) 100, b) rb anti-Mcl-1 (Abcam) with DF 100, or
c) rb anti-Bax (Abcam) with DF 200, and the final solution consisting a specific pair of
any two antibodies mentioned above were introduced to the cells for overnight incubation
at 4 °C. Further, the cells were washed 3 times for a duration of 10 min each time before
incubating at RT in the dark with the fluorophore-conjugated secondary antibody pair of
cy3 dk anti-ms IgG and FITC dk anti-rb IgG, diluted in 1x PBS at the ratios, 1:250 and
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1:150, respectively. The cells were washed twice with 1x PBS followed by a wash with
deionized water. At the end of this experiment, a few drops of Vectashield mounting
medium with 4',6-diamidino-2-phenylindole (DAPI, Vector Laboratories, CA) were
carefully placed on the slide to mount a coverslip with care. A Nikon Eclipse E400
epifluorescence microscope with objectives of 10x, 20x, 40x, 60x and 100x
magnification was used to view the immuno-stained cells. Cy3-labeled NKA was viewed
by excitation at 550 nm and emission at 570-615 nm (red fluorescence) whereas FITClabeled Bcl-2 proteins were observed by excitation at 460-500 nm and emission at 519
nm (green fluorescence). Select images were captured using a Spot camera (Diagnostic
Instruments), set up with the microscope. Final editing and colocalization of pictures
were performed using Gimp and Photoshop softwares.
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III.

RESULTS

On the interaction of pig renal Na+/K+ ATPase with Bcl-2 protein, Bak
Revealing of Bcl-2 homology (BH)-1 and BH-3 like motifs in NKA α1 by in silico
analysis (Lauf et al, 2013) sets up a background for investigating NKA’s interaction with
Bcl-2 proteins, Bcl-XL and Bak. Evidences from co-IP and ICC colocalization
experiments in FHL cells have been found to support this novel hypothesis (Lauf et al,
2015). To corroborate our previous findings and more importantly, to closely understand
the sites in Bcl-2 proteins required for its interaction with NKA, co-IP based experiments
were performed.
A Bak BH3 peptide (from Anaspec), with a preserved BH3 sequence (bold letters
LXXXGD) H-GQVGRQLAIIGDDINR-OH was incubated with equimolar concentration
of prNKA preparation for 1 h at RT. An attempt was made to pulldown this hypothetical
complex of NKA and Bak peptide by using ms anti-NKA antibody. Having the co-IP
products loaded onto a 5-20% Tris-Tricine gel and completed the transfer, the blot was
cut into two sections and probed with primary antibodies, ms anti-NKA and rb anti-Bak
(the latter from Cell Signaling, that binds to the BH3 sequence of the protein),
respectively. NKA was detected prominently in input and also in its homo-pulldown (Fig.
4A). More interesting was the appearance of a band at 25 kDa in Fig. 4B (despite the use
of Fc fragment specific secondary antibody) which could be prBAK in NKA-pulldown
and prNKA input. This finding raised a possibility of having Bak as a random
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contaminant and more as a complex-forming molecule with prNKA in this putatively
pure preparation. However, the diminutive Bak BH3 peptide with molecular weight of
merely ~2 kDa failed to be detected by the primary antibody in Fig. 4B.

Figure 4. Western blots using ms anti-NKA α1 ‘α6f’ as primary antibody and gt anti-ms
IgG L chain as secondary antibody in immunoblot (IB) A, and rb anti-Bak as primary and
anti-rb IgG Fc fragment as secondary in IB B. Molecular weight standards (MWS), co-IP
product of the same ms anti-NKA antibody, Bak BH3 peptide input and prNKA input
were loaded onto a 5-20% Tris-Tricine gel for electrophoresis.
A confirmation that 25 kDa bands detected on Fig 4B represent prBAk was important to
strengthen the concept of NKA-Bcl-2 protein interaction. prNKA suspension was
incubated with paramagnetic dynabeads for 1 h for preclearing (a step to remove nonspecific proteins from the cytosolic extract) and the resulting supernatant was used for
co-IP by ms anti-NKA, normal rb IgG and normal ms IgG. prNKA bands were detected
by ms anti-NKA (primary) and gt anti-ms IgG L chain (secondary) antibodies slightly
above 100 kDa in its self-input (homo-input) and in all co-IP lanes (Fig. 5A).
Additionally, the Dyna beads, used for initial preclearing step (however, poorly washed
before LSB/DTT treatment) were found to contain copious amount of prNKA, probably
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clung to their surface. The second blot (Fig. 5B) when probed for Bak identified putative
prBak bands at ~25 kDa; they were lightly stained in prNKA input, and darkly stained in
all co-IPs and also in the LSB/DTT extract of beads used for preclearing. As expected,
the H chain-specific secondary antibody detected ~50 kDa H chains of IgGs in all lanes.
The finding of H chain in prNKA input indicates the presence of pig IgGs as contaminant
in prNKA preparation. Moreover, Fc fragment-specific secondary antibody in IB B was
slightly cross-reactive against ms IgG L chain input, and clearly cross-reactive with rb
and ms IgG pulldowns (co-IPs in red).

Figure 5. Distinguishing prBak from IgG L chain by using normal IgG inputs as controls.
Co-IP products and inputs of both, rb IgG and ms IgG were run on a gel as additional
controls. A. Immunoblot using ms anti-NKA ‘α6f’ as primary antibody and gt anti-ms
IgG L chain as secondary antibody. B. Immunoblot developed with a combination of rb
anti-Bak as primary antibody and gt anti-rb IgG Fc fragment as secondary antibody.
To test the cross-reactivity of secondary antibody used above, the experiment in Fig. 5
was repeated with a few changes: a) adding an rb anti-Bak pulldown lane, and b) properly
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washing the beads, used for preclearing, with EBC lysis buffer before loading the
Laemmli-extraction into the last well. In Fig. 6A, the gel was probed with secondary
antibodies alone. In absence of anti-NKA antibody, gt anti-ms IgG L chain revealed no
bands. The bottom half of the gel, when treated with gt anti-rb IgG Fc fragment,
displayed the ~50 kDa H chains of IgGs, either present in the inputs or those used for the
purpose of co-IP. Moreover, a slight cross-reactivity of this secondary antibody with ms
IgG L chains was observed in input and pull down (Fig. 6B).

Figure 6. Western blots using A. gt anti-ms IgG L chain and B. gt anti-rb IgG Fc
fragment antibodies in the absence of primary antibodies used in Fig. 4 and Fig. 5. Beads
used for preclearing of prNKA preparation were washed 5 times with EBC lysis buffer
before treating with LSB/DTT mixture for extraction of bound molecules.
The experiment in Fig. 7 was a repeat of that in Fig. 6 and the blots were probed for NKA
and Bak by treating with respective primary antibodies before the secondary. In Fig. 7, IB
A shows the presence of prNKA in all co-IP samples and their self-input (red labeled),
regardless of the antibody used. The expression of prNKA band was almost completely
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eliminated by thorough washing of the beads before LSB/DTT treatment (last lane). In IB
B, the inclusion of rb anti-Bak antibody detected, in addition to the H chains seen before
with secondary antibodies alone in Fig. 6, also the ~25 kDa bands which possibly are
prBak proteins. The band was very faint in prNKA input lane, however, enriched in all
co-IP lanes and the pre-adsorbed bead extract. A soft band observed in ms IgG input
(which was also seen in Fig. 6) is now understood to be resulting from the cross reaction
of secondary antibody with ms IgG L chain.

Figure 7. Probing with specific primary antibodies to identify prNKA and prBak in the
blot. Immunoblots were prepared by employing ms anti-NKA as primary antibody and gt
anti-ms IgG L chain as secondary antibody in IB A whereas rb anti-Bak and gt anti-rb
IgG Fc fragment as primary and secondary antibody respectively in IB B. The gel was
run with the unexpended co-IP products and samples of the experiment in Fig. 6.

The immunoblot in Fig. 7B, when reprobed with IgG L chain specific secondary
antibody, produced a similar pattern of bands in Fig. 8. The bands at 25kDa region which
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most likely are the L chains of rb, ms or pig IgG (impurity in prNKA preparation) were
sharply stained. The identity of bands observed here with those in Fig. 7B casts doubts on
the 25kDa bands being exclusively prBak. H chain bands of lesser intensity were also
detected most likely due to incomplete stripping of the primary membrane.

Figure 8. Detection of IgG L chains. Western blot in Fig. 7B was stripped by incubating
at RT with stripping buffer and reprobed with rb anti-Bak primary antibody and ms antirb L chain-specific secondary antibody.
The results in Fig. 7B showed NKA also being pulled down by non-immune antibodies.
To ascertain that this pulldown was an artifact as a result of inadequate washing, the
protocol was modified by switching the washing buffer from previously used NKA buffer
to NP-40 buffer. NKA was retained in ms NKA pulldown, however, almost completely
washed off in co-immunoprecipitates of rb Bak and other non-immune antibodies: rband ms- IgGs (Fig. 9A). The appearance of 25 kDa bands was independent of NKA
pulldown, which suggests that this protein is not necessarily complexed with NKA in the
preparation (Fig. 9B).
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Figure 9. Effect of washing beads with NP-40 buffer after co-IP. The beads were washed
five times with NP-40 buffer after 2 h incubation with prNKA preparation for
immunoprecipitation. A. The immunoblot is produced by cutting off the top section of
the membrane after transfer process and incubating with ms anti-NKA primary antibody
and gt anti-ms IgG L chain-specific secondary antibody. B. Lower cut of gel was probed
with primary, rb anti-Bak and secondary, gt anti-rb IgG Fc fragment antibodies,
respectively.
The immunoblot in Fig. 9B was reprobed with rb anti-Bcl-XL primary and gt anti-rb Fc
fragment secondary antibodies, respectively (Fig. 10). Interestingly, this combination of
antibodies detected bands both at 25 kDa and 50 kDa regions in a pattern similar to that
in Fig. 7B and 9B. 50 kDa bands representing H chains is comprehensible. However, the
retention of almost the same gel pattern at 25 kDa with a different primary antibody
suggests that those bands are not specific to a primary antibody (so less likely to
represent Bak or Bcl-XL as hypothesized earlier) but might be due to cross-reactivity of
the Fc fragment specific secondary antibody.
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Figure 10. Reprobing the Western blot in Fig. 9B with anti-Bcl-XL primary antibody
(Abcam) and gt anti-rb IgG Fc fragment-specific secondary antibody.
In contrast to anti-H and L chain antibodies made against the separated, reduced and
alkylated H and L chains, respectively (Edelman and Poulik, 1961), Veriblot, a secondary
antibody produced by Abcam, has been claimed to detect only non-reduced intact
primary antibodies on the immunoblot. As this property of Veriblot could potentially
minimize the staining of H or L chains and result in a cleaner immunoblot, this secondary
antibody was acquired and used as a substitute for potentially cross-reactive gt anti-rb Fc
secondary antibodies used in all previous works. NKA was prominently stained in input
and to a lesser degree in homo-pulldown in conformity with our previous findings (Fig.
11A). Veriblot completely eliminated all the bands at 25 kDa ‘verifying’ that those were
actually L chains but not prBak as surmised previously. Veriblot was, however, found to
partially cross-react with H chains.

27

Figure 11. Using Veriblot as secondary antibody. Western blots were produced by usingA. ms anti-NKA as primary antibody and gt anti-ms IgG L chain as the secondary, and B.
rb anti-Bak and Veriblot as primary and secondary antibody, respectively. All other
procedures were followed exactly the same way as for the experiment in Fig. 9.
Re-probing the immunoblot in Fig. 11 with the previously used H chain specific
secondary antibody reproduced the 25 kDa bands. These bands have now been shown to
be IgG L chains originating from either the denaturation of co-IP antibodies or of pig IgG
contaminating the prNKA preparation.
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Figure 12. Reprobed Western blot result of Fig. 11B using anti-rb IgG Fc fragment
specific secondary antibody against rb anti-Bak primary antibody.
In summary, this entire series of co-IP experiments on prNKA preparation was actuated
by an initial finding of 25 kDa bands on the immunoblot. Though this protein was
initially hypothesized to be Bak interacting with prNKA in the preparation, further
confirmatory experiments have unequivocally established that these bands most likely
represent L chains stained due to the cross-reaction of Fc fragment-specific secondary
antibody. The use of Veriblot secondary antibody was an important step in this
troubleshooting process as it resulted in cleaner gels at the expense of L chain detection, a
potential confounding factor for immunoblotting studies of Bcl-2 proteins like Bak.
Realization of this prospect prompted us to review some of our previous co-IP results,
published in American Journal of Physiology in 2015, that demonstrated the interaction
of NKA with Bcl-2 proteins for the first time.
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Reassessing the co-immunoprecipitation of Bak by NKA in FHL 124 cells
Based on evidences from co-IP and immuno-colocalization, it has been proposed that
Bak, a pro-apoptotic Bcl-2 protein, interacts with NKA α1 subunit in FHL 124 cells
(Lauf et al, 2015). The data on ICC in this paper convincingly demonstrated the
proximity of two proteins, however, some anomalies were present in its co-IP results.
NKA failed to pull down ~23 kDa Bak protein (detected in homo-pulldown and FHL
input), however, produced a band at ~27 kDa, which was proposed to be a spliced
isoform of Bak with 4 kDa higher molecular weight. Since the Fc fragment-specific
secondary antibody (Abcam), used to generate these data, has now been shown to crossreact towards L chains, it was necessary to check the accuracy of these data. Moreover,
the use of Veriblot secondary antibody, that reportedly detects only non-reduced intact
IgGs, could provide more credibility to these results by eliminating the confounding
detection of L chains.
Co-IP experiments were again performed with anti-Bcl-XL (Abcam), anti-NKA α6f
(DSHB) and anti-Bak (Santa Cruz) antibodies in order to pull down specific proteins
from FHL cell lysate. Normal ms and rb IgG from Santa Cruz were used as controls for
co-IP. After completing the transfer of proteins from a 12.5 % Tris-HCl gel (Biorad,
provides a greater separation of proteins at lower molecular weights) onto a nitrocellulose
membrane, the membrane was probed for Bak using rb anti-Bak antibody (Santa Cruz)
coupled with Veriblot secondary antibody from Santa Cruz (Fig. 13). Bak (~25 kDa) was
observed in FHL input, homo-pulldown of anti-Bak and also in anti-Bcl-XL pulldown.
However, the band was missing in the co-IP product of the anti-NKA antibody. Bands of
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~27 kDa which might represent L chain were also detected in Bcl-XL through IgG ms
pulldown lanes on the gel.

Bak

Figure 13. Western blot using rb anti-Bak (from Santa Cruz) as primary antibody and
Veriblot (Abcam) as secondary antibody. Antibody loaded Dyna beads were treated with
FHL cell lysate, extracted with NP-40 buffer, containing ~500 µg of protein for co-IP and
the pulldown products with input and MWS (far left) loaded into separate wells of a
12.5% Tris-HCl gel (Bio Rad). Left: Molecular weight standards and identity of
significant bands.
A different gel prepared by repeating the above experiment in Fig. 13 was probed using
anti-NKA α6f primary antibody that detected NKA only in FHL input and in NKA
homo-pulldown (Fig. 14). This is consistent with earlier findings published in American
Journal of Physiology (Lauf et al, 2015) which also could not demonstrate reciprocal coIP of NKA by either Bcl-XL or Bak. The results in Fig. 13 and 14 unambiguously
suggests that NKA could not pull down Bak and vice versa in the present experimental
conditions.
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NKA

Figure 14. Western blot obtained by probing with anti-NKA ‘α6f’ as primary antibody
and gt anti-ms IgG L chain as secondary antibody. Co-IP products are labelled red and
molecular weight standards along with identity of bands are displayed on the left of the
figure.

Immuno-colocalization of Bak and NKA in fetal human lens (FHL) 124 epithelial
cells
In FHL cells cultured on an EZ chambered slide (Millipore), Bak was stained green with
a FITC fluorophore (Fig. 15 A) whereas NKA red with cy3 (Fig. 15 B). The green label
of Bak in Fig. 15A mimics a typical arrangement of microtubules in the spindle apparatus
formed during the early phase of mitotic cell division. The overlap of these two images,
shown in Fig. 15 C, reveals yellow regions representing colocalization of two proteins
mostly on the periphery of the cell. These data confirm the immuno-cytochemical
colocalization reported earlier (Lauf et al, 2015) and suggest that NKA and Bak proteins
interact in the cellular environment, but that interaction appears to be lost upon cellular
solubilization and extraction of NKA and Bak by co-IP.
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Moreover, in order to obviate the possibility of non-specific staining by the fluorophore
conjugated secondary antibody (which might be potentially contaminated with other IgGs
during its isolation process), FHL cells on four separate wells of the same chamber slide
were treated simultaneously with the secondary antibody alone without the prior
treatment of specific primary antibodies. This resulted in the absolute absence of green
and red fluorescence on cells containing the DAPI-stained nuclei (results not shown).

Figure 15. Immunofluorescence staining of an FHL 124 cell using A. rb anti-Bak (Santa
Cruz) and FITC dk anti-rb IgG (Jackson Immunoresearch); B. ms anti-NKA α1
(Millipore) and cy3 dk anti-ms IgG (Jackson Immunoresearch). C. displays the overlap of
images A and B. D. final merge of image C with DAPI staining. (observed under 100x
objective using immersion oil).
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Revisiting the co-immunoprecipitation of Bcl-XL by NKA in FHL 124 cells
The interaction between Bcl-XL and NKA has been unequivocally demonstrated by coIP and immuno-cytochemical colocalization in FHL 124 cells (Lauf et al, 2015). Unlike
Bak, the results based on co-IP experiments in this paper show a distinct Bcl-XL band at
~27 kDa in FHL input, anti-Bcl-XL homo-pulldown, and also in NKA pulldown. As the
outcome of confirmatory works with Veriblot secondary antibody on Bak pulldown was
inconsistent with respect to our previous claims, we were interested to carry out similar
experiments for Bcl-XL and test this null hypothesis of NKA-Bcl-2 proteins interaction.
FHL cell lysate, extracted with RIPA buffer, was precleared by incubating with IgG
conjugated paramagnetic Dyna beads for 2 h. Volumes of FHL lysate equivalent to 500
µg of protein were introduced to tubes containing 50 µL of Dyna beads already treated
with specific antibodies for immunoprecipitation (Fig. 16). After 2 h incubation on a
rotor (Fisher Scientific), the samples were washed, treated with LSB/DTT and finally
loaded onto a 12.5 % Tris-HCl gel. After electrophoresis and subsequent transfer onto a
nitrocellulose membrane, the membrane was cut into sections, Fig. 16A and 16B, which
were probed for NKA and Bcl-XL respectively. Fig. 16A, which reveals NKA only in
input and anti-NKA homo-pulldown, is consistent with our past findings published in
AJP. However, in Fig. 16B, the use of Veriblot as a secondary antibody for rb anti-BclXL primary antibody unveils Bcl-XL (~27 kDa) only in FHL input and anti-Bcl-XL
homo-pulldown. This result directly contradicts previous findings of our group (Lauf et
al, 2015) that reveals Bcl-XL being co-immunoprecipitated by NKA in FHL cells.
Nevertheless, the absence of Bcl-XL in Bak co-IP, the positive control here, gives us
enough reasons to doubt the technical accuracy of this experiment.
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NKA

Bcl-XL

Figure 16. Western blotting of A. NKA using ms anti-NKA (primary) and gt anti-ms L
chain specific (secondary) antibodies, and B. Bcl-XL using rb anti-Bcl-XL (primary) and
Veriblot (secondary) antibodies. Immunoprecipitation of specific antibodies from FHL
cell lysate, extracted with RIPA buffer, was performed with respective antibodies shown
in red. Molecular weight standards and significant bands are shown on the left.
The co-IP of Bcl-XL by NKA might be dependent on the duration of incubating FHL cell
lysate with antibody-bound beads during the immunoprecipitation step. Results in Fig. 16
were obtained with incubation time of 2 h which is much shorter compared to overnight
incubation performed for Bcl-XL co-IP results published in the AJP paper, 2015.
Therefore, we were interested to see if the published results could be reproduced by
increasing the incubation time. The co-IP samples, generated with different antibodies
shown in red, were loaded in duplicate in order to get two separate immunoblots shown
in Fig. 17A and 17B, prepared respectively by using gt anti-rb IgG Fc fragment and
Veriblot secondary antibodies against the same rb anti-Bcl-XL primary antibody. In
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Figure 17A, Bcl-XL (~27 kDa) was detected in input and anti-Bcl-XL homo-pulldown.
Background staining of less intense 27 kDa bands from NKA through IgG ms pulldowns
might be of less significance. Moreover, potential L chains at 25 kDa might have been
detected due to cross-reactivity of gt anti-rb IgG Fc fragment secondary antibody. On the
other hand, rb anti-Bcl-XL with Veriblot secondary antibody reveals Bcl-XL in FHL
input and homo-pulldown only. Additionally, bands with lesser intensity were detected at
all the lanes just above 27 kDa. Their potential identity as L chains was not checked in a
separate experiment. Their appearance in normal rb and ms IgG pulldowns and also being
located clearly above the sharp Bcl-XL bands appears to be inconsistent with the
possibility of these protein bands being Bcl-XL. However, the absence of Bcl-XL in Bak
pulldown definitely compromises the reliability of our method for co-IP.

A

Bcl-XL
L chain
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B

Bcl-XL

Figure 17. Immunoblots prepared by using rb anti-Bcl-XL as primary and gt anti-rb IgG
Fc fragment (A) and Veriblot (B) as secondary antibodies. A 12.5 % Tris-HCl gel
providing a greater separation at lower molecular weights was used for both gel results.
Co-IP products are shown in red. Molecular weight markers and identity of significant
bands are displayed on the left.

37

Study of interaction between Mcl-1 and NKA by co-IP and immuno-colocalization
Mcl-1 is another member of Bcl-2 protein family, having anti-apoptotic properties similar
to that of Bcl-XL. Structurally, this unstable protein is of higher molecular weight
(approx. 45 kDa) and has a long tail towards its BH4 domain. These unique properties
could render different binding characteristics to Mcl-1compared to its counterparts.
Revised co-IP studies on Bak and Bcl-XL gave negative results. Veriblot secondary
antibody proved to be instrumental in identifying specific bands of interest by eliminating
L chains from the immunoblot. Since the usage of L chain or Fc fragment specific
secondary antibodies had earlier produced complicated gel results for similar co-IP
studies on Mcl-1, we exploited the superior features of Veriblot to troubleshoot this issue.
Anti-Mcl-1 (Abcam), anti-NKA ‘α6f’ (DSHB), anti-NKA (Abcam), anti-Bax (Abcam),
normal IgG rb and normal IgG ms antibodies were used to immunoprecipitate respective
proteins from FHL lysate. The products of co-IP were hence loaded into wells of a selfpoured 10% polyacrylamide gel containing 0.1 % SDS in an order shown Fig. 18. After
electrophoresis at a constant voltage of 100 V for 1 h (in stacking gel) followed by 150 V
for 3 h (in resolving gel), transfer of proteins from gel onto a nitrocellulose membrane
was accomplished at 70 mAmp constant current in 16 h. The upper section of the
membrane (Fig. 18A), probed for NKA, reveals NKA in anti-NKA homo-pulldowns,
however, this band was missing in FHL input for unknown reasons. In Figure 18B, Mcl-1
was detected in FHL input and anti-Mcl-1 homo-pulldown at ~45 kDa region. Mcl-1 also
failed to co-IP with Bax as expected because Mcl-1 is known to form hetero-dimers with
Bak but not Bax (Willis et al, 2005).
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NKA

Mcl-1

Figure 18. Immunoblots prepared by using A. ms anti-NKA ‘α6f’ as primary and
Veriblot as secondary antibodies, and B. rb anti-Mcl-1 and Veriblot respectively as
primary and secondary antibodies. Molecular weight markers and identity of significant
bands are labelled on the left of the figure.

Immuno-colocalization of Mcl-1 and NKA in Fetal Human Lens (FHL) 1epithelial
cells
Employing immunofluorescence technique, Mcl-1 and NKA in FHL cells cultured on a
EZ chambered slide (Millipore) were labelled green with FITC and red with cy3 dyes
respectively (Fig. 19A and B). The overlap of Fig. A and B in C displayed orange colored
areas towards the cell membrane where the two proteins could lie in proximity and hence
interact. D is the fusion of C and DAPI staining of the cell.
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Figure 19. Immunofluorescence staining of an FHL cell with A. rb anti-Mcl-1 (Abcam)
and FITC conjugated dk anti-rb IgG (Jackson Immunoresearch); and B. ms anti-NKA
(Millipore) and cy3 conjugated dk anti-ms IgG (Jackson Immunoresearch). C. the merger
of A and C, and D. of C and DAPI staining. (observed under 100x objective using
immersion oil).

Immuno-colocalization of Bax and NKA in FHL 124 cells
Bax and NKA in FHL cells were immuno-labelled green and red with FITC- and cy3conjugated secondary antibodies targeted against rb anti-Bax and ms anti-NKA primary
antibodies respectively (Fig. A and B of 20 I and II). Fusion of images A and B showed
yellow and orange areas, where NKA and Bak could be potentially co-localized (Fig. C
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of 20 I and II). Figure D of both 20 I and II are the final merger of image C with DAPI
staining of cells.

20 I

20 II
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Figure 20. (I and II): Immunofluorescence results of FHL cells stained with A. rb antiBax (Abcam) and FITC-conjugated dk anti-rb IgG (Jackson Immunoresearch) as primary
and secondary antibodies respectively; and B. ms anti-NKA (Millipore) and cy3conjugated dk anti-ms IgG (Jackson Immunoresearch) as primary and secondary
antibodies respectively. C. Fusion of figures A and B. D. Fusion of image C with DAPI
staining of the same cells. (observed under 100x objective using immersion oil)
Basically, Mcl-1 followed the other proteins in failing to reveal interaction with the NKA
in co-IP experiments, while both Mcl-1 and Bax co-immunolocalized with NKA.

42

IV.

DISCUSSION AND CONCLUSION

Revealing of aa sequences in NKA α1 subunit- a) ARAAEILARDGPN (aa 59-71)
homologous to the BH1 motif, b) DELHRKY (aa 42-48) homologous to the BH3 motif,
and c) RDGVNDS (aa 709-715, similar to BH1 like motif 67-71 in (a), however, solvent
inaccessible, and, possibly exposed during the conformational changes in its catalytic
cycle) BH1 like motif- was a landmark in the study of interaction between NKA and Bcl2 proteins (Lauf et al, 2013). This finding led to a hypothesis that NKA combines with
Bcl-2 proteins by virtue of BH1/BH3 motif interactions. Subsequent experiments on coIP and immunocytochemistry provided evidences in support of this hypothesis. NKA coimmunoprecipitated Bcl-XL and a putative splice variant of Bak with molecular weight
~4kDa higher compared to the normal one detected in input and homo-pulldown in FHL
cell lysates. Additionally, immunofluorescence studies established the colocalizaton of
NKA with Bcl-XL and Bak in separate experiments performed on cell cultures of FHL
epithelial cells. Based on these findings, it had been proposed that NKA interacts with
Bcl-XL and Bak (Lauf et al, 2015).
Having demonstrated the interaction by immunochemical techniques, it was
necessary for us to confirm whether the BH1 and BH3 like motifs identified in α1 subunit
were fundamental for its affinity towards these Bcl-2 proteins. Moreover, we were also
interested to learn whether NKA interacts with other members of the Bcl-2 protein
family. To answer our first question, an attempt was made to form a complex of isolated
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and purified prNKA with a Bak BH3 eicosapeptide (with approximately 2 kDa molecular
weight) with a known sequence (H-GQVGRQLAIIGDDINR-OH) when incubated
simultaneously. The conserved BH3 motif (shown in bold) was expected to bind with a
BH1 like hydrophobic pocket in NKA. A co-IP experiment using anti-NKA antibody was
performed to test this hypothesis and the resulting pull down product was tested for the
presence of BH3 peptide by probing the immunoblot with anti-Bak antibody (having
BH3 domain as its antigenic sequence). The small Bak BH3 peptide (of 2 kDa mol. wt.)
was not detected in any of the lanes in our gel result (Fig. 4). Although we had used a 520% Tris-Tricine gel (Bio Rad), which is used to separate proteins as small as 2 kDa,
under our experimental conditions, the peptide appears to have over-run the gel during
electrophoresis. Another possible explanation might be the steric hindrance of the antiBak primary antibody precluding its firm binding to the peptide. Thus, the concept that
NKA could form a complex with this peptide remains inconclusive in light of our
technical limitations.
The detection of ~25 kDa bands on these immunoblots was a promising prospect
for us as it was initially thought to be the Bak protein forming a complex with prNKA in
the preparation. This assumption was sensible given that the prNKA preparation,
received from Dr. Judy Heiny, had not been titrated with SDS- the last step of Klodos
procedure (2002) for large scale preparation of NKA that would have otherwise removed
extraneous proteins from the microsomal fraction but, leaving NKA membrane bound.
Nevertheless, the gel results were not devoid of flaws. NKA was not only observed in
specific anti-NKA and anti-Bak co-IP products but also noticed in non-immune IgG ms
and rb pull downs in several of our initial experiments (Fig. 5 and 7). In a similar manner,
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putative Bak bands were also observed exclusively in all co-IP lanes prompting us to
believe that NKA might have co-immunoprecipitated this protein. As a by-product of this
study, we noted that the Fc fragment-specific secondary antibody detected heavy chains
in all the samples including prNKA input and the beads used in the initial preclearing
step. This finding suggested that the prNKA preparation contained pig IgG as one of the
contaminants.
The issue of NKA detection in non-immune IgG pull downs was solved by
switching the buffer from previously used NKA buffer to NP-40 buffer for the final
washing step of co-IP (Fig. 9 and 11). The appearance of near 25 kDa bands was,
however, unresponsive, to the stringent washing by NP-40 buffer and persisted in all the
lanes (Fig. 9 and 12) despite NKA’s elimination, casting a doubt on these bands being
solely Bak. Immunoblotting by Fc fragment-specific gt anti-rb IgG secondary antibody
alone in the absence of anti-Bak primary antibody unveiled the partially cross-reactive
nature of this secondary antibody against the L chain of ms IgG (Fig. 6). To authenticate
the existence of Bak, several other confirmatory experiments were performed: i) coupling
the anti-Bak primary antibody with gt anti-rb IgG L chain secondary antibody gave
similar results as given by the Fc specific secondary antibody (Fig. 8); ii) probing with
anti-Bcl-XL primary antibody also yielded an almost similar gel pattern (Fig. 10); and iii)
most notably, the use of Veriblot secondary antibody against intact (non-reduced) antiBak primary antibody completely eliminated all ~25 kDa bands (Fig. 11). All these
results seem to be inconsistent with our initial assumption that ~25 kDa bands could be
Bak. Contrarily, these bands appear to be the L chains potentially detected on the
immunoblots due to the cross-reaction of the secondary antibody used.
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This co-IP based study on prNKA, despite yielding results which appear to
contradict our initial hypothesis, enlightened us on two major aspects. The first
information gained from here is that the unexpected L chain detection by the secondary
antibody in immunoblots could be a potential confounding factor for the interpretation of
the immunoblots of Bcl-2 proteins with close molecular weights. Secondly, Veriblot
could be an important tool for future experiments as it yields cleaner gels by not binding
to L chains and/or H chains. Moreover, analyzing these results on a broader perspective,
it is most likely that NKA’s interaction with Bcl-2 proteins might be sensitive to changes
in the ionic and pH environment so that with the rigorous extraction process that includes
numerous steps of freezing, thawing, homogenization, centrifugation, and solvent
changes, the interaction between NKA and Bcl-2 proteins could have been disrupted.
Furthermore, it is also necessary for us to repeat the experiment in Fig. 4 to confirm if at
all the BH1/BH3 interaction between NKA with the Bak BH3 peptide can be induced in
situ and subsequently demonstrated by co-IP under controlled conditions.
The second section of this present study deals with immunochemical experiments
performed on FHL cell lysates and culture, and aimed at confirming our previous
findings that provide evidence for direct physical interaction of NKA with Bcl-XL and
Bak. As Veriblot superseded previously used secondary antibodies in these experiments,
detection of and interference by L-chain or H-chain was expected to be resolved.
Previously published work of Lauf et al (2015) on Bak-NKA interaction had revealed
~27 kDa bands in NKA- and Bcl-XL pull-down samples in contrary to ~23 kDa proteins
detected by anti-Bak primary antibody in input and homo-pulldown. This finding led to
an assumption that a higher molecular weight spliced isoform of Bak might interact with
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NKA and Bcl-XL. A reassessment study using Veriblot secondary antibody revealed ~23
kDa bands in input, homo-pulldown, and in Bcl-XL pulldown (serving as a positive
control as Bcl-XL interacts with Bak; Willis et al, 2015), however, such a band was
missing in the co-IP product of NKA (Fig. 13). The ~27 kDa bands were detected by
Veriblot too but could less likely be Bak spliced variants as they were also expressed in
equal intensities on normal IgG ms and rb pulldown lanes. Moreover, in conformity with
earlier results, neither Bak nor Bcl-XL reciprocally pulled down NKA from the FHL
lysate. Both of these observations strongly suggest that NKA-Bak interaction, attempted
to be demonstrated here, might not be evidenced by co-IP under our experimental
conditions. In contrast to these findings, promising results were observed with
immunocytochemistry. In Fig. 15, NKA and Bak evidently colocalized in the periphery
of the FHL cell. Moreover, a control experiment performed in parallel by treating the
cells with only the fluorophore conjugated secondary antibody confirmed the specificity
of green and red staining of Bak and NKA respectively, strengthening the accuracy of our
colocalization results in Fig. 15. These findings conform to the earlier ICC based results
by Lauf et al (2015) showing colocalization of Bak and NKA in FHL cells and also
supports the notion that they lie in close proximity in FHL cells and could therefore,
interact.
The previously reported co-IP results (by Lauf et al, 2015) demonstrating the interaction
of NKA and Bcl-XL were unequivocal. However, with contradictory results observed
with Bak, it was crucial for us to confirm our previous findings and statements on NKABcl-XL interaction. Neither Veriblot nor the conventionally used Fc fragment-specific gt
anti-rb IgG secondary antibodies coupled with anti-Bcl-XL primary antibody for
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immunoblotting could reproduce the co-IP of Bcl-XL by NKA (Fig 16 and 17). These
data are inconsistent with our previous findings. However, the fact that that Bcl-XL
bands are also missing in the Bak co-IP (positive control) lanes questions the credibility
of the current data. This also requires us to revisit our co-IP technique with special focus
on cell extraction buffer for demonstrating NKA-Bcl-XL protein interaction. On the other
hand, as we acknowledge the cross reactivity of Fc fragment-specific secondary antibody
against the L chain of ms IgG, it is also equally possible that the L chains in ms-antiNKA pull-downs might have been misconstrued as Bcl-XL in the previous results.
Mcl-1 is a multi-domain Bcl-2 family protein having anti-apoptotic properties similar to
that of Bcl-XL. Of all Bcl-2 family proteins, Mcl-1 forms heterodimers only with Bak
keeping the latter in an inactive state. However, no concrete evidences have been found
to suggest its interaction with Bax (Willis et al, 2005). Marked protein instability, higher
molecular weight and having a long tail towards the B4 domain are other features
characteristic to Mcl-1 compared to other anti-apoptotic proteins. For this reason, we
were interested to see how its interaction with NKA will differ from others. In a co-IP
experiment depicted in Fig. 18, Mcl-1 was pulled down by neither of the anti-NKA
antibodies, however, was detected as a ~45 kDa band in FHL input and homo-pulldown.
Bax co-IP has erroneously been used as a positive control here as we know now that it
does not readily interact with Mcl-1.
Immunofluorescence experiments performed on FHL cells (Fig. 19 and 20), nevertheless,
convincingly demonstrated the colocalization of NKA with Mcl-1 and Bax. Despite the
inability of co-IP results to verify the direct physical interaction between these proteins,
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these data derived from immunocytochemistry strongly suggests that these are localized
in close proximity within the FHL cells and might interact with each other.
In summary, our co-IP results seem to be inconsistent with the findings of ICC. To
provide a supporting rationale to explain this aberration, it is pertinent to discuss some of
the factors that might have contributed to the disruption of protein-protein interactions
during our co-IP procedure. The buffer used for the extraction of proteins from cells
could be vital to preserve the interaction between proteins. The RIPA buffer, which was
used as extraction buffer for our work on Bcl-XL and Mcl-1 co-IP, is a stringent buffer
and has been contraindicated for the study of protein-protein interactions. It is also quite
likely that NKA’s interaction with Bcl-2 proteins might be conformation dependent.
Under the homeostatic conditions inside an FHL cell, NKA might be able to attain a
suitable conformation to interact with Bcl-2 proteins as evidenced by ICC. However,
during the extraction procedure, changes in the pH and ionic environments aggravated by
the lack of its specific binding partners and ATP, and also the denaturing properties of
detergents used during extraction and as washing buffers could potentially alter the
conformation of NKA, making it less suitable to bind with Bcl-2 proteins. Moreover, the
pumping activity of NKA is found to be dependent on the presence of membrane lipids
and cholesterol (Lucio et al, 1991). Consequently, divesting NKA of its associated
membrane lipids by extraction and purification (as in the prNKA preparation) could
potentially change its binding properties also. Finally, in order to resolve the discrepancy
between the results of co-IP and ICC, it might be proposed that NKA, in spite of
interacting directly, could be associated with Bcl-2 proteins via connector proteins. The
IP3 receptor, that has been demonstrated to bind with both NKA (Aizman et al, 2001)
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and Bcl-2 proteins (Parys, 2014) through specific domains, could be an example of such
connector proteins. The cytoskeleton proteins like tubulins could also serve a similar role
as it can also interact with both NKA (Amaiden et al, 2011) and Bcl-2 proteins (Knipling
and Wolff, 2006).
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